Toxoplasmosis and clindamycin.
D002981:Clindamycin / Q000009:adverse effects* / Q000627:therapeutic use; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced; D006801:Humans; D014123:Toxoplasmosis / Q000188:drug therapy*
D002981:Clindamycin